KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $5.7 billion.

  • Pfizer's Shares Outstanding (Diluted Average) rose 15.78% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 15.78%. This contributed to the annual value of $5.7 billion for FY2024, which is 15.76% down from last year.
  • Latest data reveals that Pfizer reported Shares Outstanding (Diluted Average) of $5.7 billion as of Q3 2025, which was up 15.78% from $5.7 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Shares Outstanding (Diluted Average) registered a high of $5.8 billion during Q2 2022, and its lowest value of $5.7 billion during Q2 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $5.7 billion, with a median of $5.7 billion in 2025.
  • As far as peak fluctuations go, Pfizer's Shares Outstanding (Diluted Average) skyrocketed by 169.55% in 2022, and later tumbled by 53.84% in 2023.
  • Pfizer's Shares Outstanding (Diluted Average) (Quarter) stood at $5.7 billion in 2021, then rose by 0.44% to $5.7 billion in 2022, then fell by 0.42% to $5.7 billion in 2023, then dropped by 0.16% to $5.7 billion in 2024, then rose by 0.25% to $5.7 billion in 2025.
  • Its last three reported values are $5.7 billion in Q3 2025, $5.7 billion for Q2 2025, and $5.7 billion during Q1 2025.